Lianhuan Pharmaceutical: net profit loss of 98.33 million yuan in 2025

Lianhuan Pharmaceutical announced that its operating income in 2025 was 2.712 billion yuan, a year-on-year increase of 25.52%. The net loss was 98.3324 million yuan, compared to a net profit of 84.16 million yuan in the same period last year. It is planned to distribute cash dividends of 0.70 yuan per 10 shares to all shareholders based on the total share capital on the date of registration of equity distribution for the 2025 fiscal year, with a total distribution of 199.819 million yuan.